4 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow Criminal Behavior: new trials by email Literature Review of Criminal Behavior trials Research Report on Criminal Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Impact and Detection of Driving Impairments Associated With Acute Cannabis Smoking Cannabis - Cannabis Intoxication | Phase 1 / Phase 2 | Completed | University of California, San Diego | 199 | 2017-02-24 | 2022-01-04 |
| Evaluation of an School-based Alcohol Prevention Program for Middle School Students Click City®: Alcohol - Alcohol-related Disorders, Drinking and Driving | Phase 2 | Completed | Oregon Research Institute | 2300 | 2012-11-01 | 2016-10-06 |
| The Impact of Psychopathic Traits on the Efficacy of a Substance Use Intervention motivational enhancement therapy, standard care - Substance Use, Psychopathy | Phase 2 | Completed | University of Rochester | 105 | 2009-08-01 | 2016-12-12 |
| Recovery Management Checkups for Women Offenders Recovery Management Checkups, Outcome Monitoring - Recovery Management Checkup (RMC), Outcome Monitoring | Phase 2 | Completed | Chestnut Health Systems | 480 | 2007-07-01 | 2015-07-29 |
Driving Under the Influence (2) · Recidivism (2) · Substance-Related Disorders (2) · Alcohol-Related Disorders (1) · Antisocial Personality Disorder (1) · Marijuana Abuse (1) · Memory Disorders (1) · Neurologic Manifestations (1)
Behavior (4) · Chemically-Induced Disorders (4) · Mental Disorders (4) · Dangerous Behavior (2) · Nervous System Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Substance-Related Disorders (2) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Personality Disorders (1)
Ethanol (1) · Motivational Interviewing (1) · Standard of Care (1) · nabiximols (1)
Chestnut Health Systems (1) · Oregon Research Institute (1) · University of California, San Diego (1) · University of Rochester (1)
United States (4)
Judy Andrews, Ph.D. (1) · Marc T. Swogger, Ph.D. (1) · Thomas D Marcotte, PhD (1)
PMID 22542465, PMID 26727409, PMID 30615854, PMID 31527291, PMID 34173005, PMID 34185831, PMID 35080588, PMID 37531115
K23DA027720 (1), R01AA019671 (1), R01DA021174 (1)